Eleni H Moschonas
Overview
Explore the profile of Eleni H Moschonas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Race N, Moschonas E, Kline A, Bondi C
Adv Neurobiol
. 2024 Oct;
42:219-240.
PMID: 39432045
Elderly individuals (65 years and older) represent the fastest-growing demographic of new clinical traumatic brain injury (TBI) cases, yet there is a paucity of preclinical research in aged animals. The...
2.
Moschonas E, Annas E, Zamudio-Flores J, Jarvis J, Lajud N, Bondi C, et al.
Adv Neurobiol
. 2024 Oct;
42:147-163.
PMID: 39432041
Pediatric traumatic brain injury (TBI) is a significant healthcare issue, but potential treatments are absent despite robust investigation in several clinical trials. Factors attributed to clinical TBI, such as heterogeneity...
3.
Bittner R, Greene A, Leary J, Donald H, Capeci H, Moschonas E, et al.
Brain Res
. 2024 Oct;
1846():149281.
PMID: 39423964
Environmental enrichment (EE) consists of increased living space, complex stimuli, and social interaction that collectively confer neurobehavioral benefits in preclinical models of traumatic brain injury (TBI). The typical EE approach...
4.
Moschonas E, Steber J, Capeci H, Donald H, Vozzella V, Bittner R, et al.
Exp Neurol
. 2024 Oct;
383():114990.
PMID: 39389162
The robustness of environmental enrichment (EE) in ameliorating neurobehavioral and cognitive deficits after experimental traumatic brain injury (TBI) is unequivocal. What is equivocal is whether EE can function as a...
5.
Moschonas E, Capeci H, Annas E, Domyslawski V, Steber J, Donald H, et al.
J Neurotrauma
. 2024 Jul;
41(21-22):2428-2441.
PMID: 38994598
Cholinergic disruptions underlie attentional deficits following traumatic brain injury (TBI). Yet, drugs specifically targeting acetylcholinesterase (AChE) inhibition have yielded mixed outcomes. Therefore, we hypothesized that galantamine (GAL), a dual-action competitive...
6.
Kline A, Moschonas E, Bondi C
Neural Regen Res
. 2024 Mar;
19(10):2105-2106.
PMID: 38488540
No abstract available.
7.
Vozzella V, Bittner R, Ranellone T, Grimm K, Palmer K, Carpio A, et al.
Exp Neurol
. 2023 Dec;
373():114648.
PMID: 38081352
Environmental enrichment (EE) facilitates motor and cognitive recovery after traumatic brain injury (TBI). Historically, EE has been provided immediately and continuously after TBI, but this paradigm does not model the...
8.
Race N, Moschonas E, Cheng J, Bondi C, Kline A
Neurotrauma Rep
. 2023 Nov;
4(1):724-735.
PMID: 37928134
Sixty-nine million traumatic brain injuries (TBIs) are reported worldwide each year, and, of those, close to 3 million occur in the United States. In addition to neurobehavioral and cognitive deficits,...
9.
Amirbekyan M, Adhikarla V, Cheng J, Moschonas E, Bondi C, Rockne R, et al.
Sci Rep
. 2023 Oct;
13(1):17874.
PMID: 37857701
Efficacious stem cell-based therapies for traumatic brain injury (TBI) depend on successful delivery, migration, and engraftment of stem cells to induce neuroprotection. L-myc expressing human neural stem cells (LMNSC008) demonstrate...
10.
Moschonas E, Ranellone T, Vozzella V, Rennerfeldt P, Bondi C, Annas E, et al.
Exp Neurol
. 2023 Sep;
369:114544.
PMID: 37726048
Traumatic brain injury (TBI) causes neurobehavioral and cognitive impairments that negatively impact life quality for millions of individuals. Because of its pernicious effects, numerous pharmacological interventions have been evaluated to...